data_2gql_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gql _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -163.12 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 129.766 3.226 . . . . 10.0 112.723 -6.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 177.99 0.79 Allowed 'General case' 0 N--CA 1.476 0.831 1 C-N-CA 132.076 4.151 . . . . 10.0 111.953 -0.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.47 16.16 24.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.91 1.719 . . . . 10.0 113.529 165.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.517 ' HZ2' ' CD ' ' A' ' 272' ' ' GLU . 8.8 tmtt? -155.45 132.94 6.5 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 118.749 1.275 . . . . 10.0 110.541 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.89 147.35 39.0 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.174 2.583 . . . . 10.0 112.902 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' H ' ' CD2' ' A' ' 135' ' ' LEU . 1.4 pt? -79.17 44.44 0.58 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.004 2.122 . . . . 10.0 113.726 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 mp -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.11 1.364 . . . . 10.0 113.448 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.95 -119.05 4.96 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.4 -2.28 . . . . 10.0 107.4 -153.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 160.83 34.44 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 122.429 -0.454 . . . . 10.0 114.163 163.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.64 50.85 2.74 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.34 2.694 . . . . 10.0 109.987 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.33 159.1 21.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.641 0.608 . . . . 10.0 112.641 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.0 p -139.94 63.23 1.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.557 0.947 . . . . 10.0 113.557 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.29 139.12 31.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 119.447 -2.033 . . . . 10.0 112.687 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.5 m -70.71 151.72 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.439 1.496 . . . . 10.0 109.168 170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 p -103.24 154.26 19.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.12 1.368 . . . . 10.0 111.658 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -56.63 -21.91 30.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 10.0 113.361 164.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -78.51 -9.78 59.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.841 2.056 . . . . 10.0 112.322 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 -8.94 73.64 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.636 1.112 . . . . 10.0 114.318 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.38 179.86 7.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.643 1.577 . . . . 10.0 110.188 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.5 103.16 4.06 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.58 -1.325 . . . . 10.0 111.34 -167.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 162.04 13.64 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.659 1.355 . . . . 10.0 114.659 -170.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -117.82 175.84 5.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.537 1.535 . . . . 10.0 109.383 158.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -70.3 -22.11 62.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.099 1.36 . . . . 10.0 113.252 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -12.16 47.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.1 1.148 . . . . 10.0 114.1 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -27.62 69.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.633 1.573 . . . . 10.0 111.501 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -94.93 6.23 49.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.402 1.481 . . . . 10.0 114.346 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.68 106.53 1.2 Allowed 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.277 -0.89 . . . . 10.0 111.307 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 153.18 -37.63 0.74 Allowed Glycine 0 N--CA 1.47 0.941 0 C-N-CA 124.076 0.846 . . . . 10.0 113.412 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -166.06 1.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.582 1.153 . . . . 10.0 110.101 167.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -103.75 169.89 8.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.457 1.103 . . . . 10.0 111.644 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.53 155.2 49.53 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.509 1.124 . . . . 10.0 112.043 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -120.16 120.18 35.45 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.949 -1.5 . . . . 10.0 106.949 154.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mt -105.52 131.81 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.635 1.174 . . . . 10.0 108.885 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -140.21 135.4 32.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.125 0.97 . . . . 10.0 111.722 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.76 114.52 26.17 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.762 0.825 . . . . 10.0 110.77 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.5 167.69 13.28 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.877 1.703 . . . . 10.0 114.319 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -159.1 114.7 2.55 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.431 1.092 . . . . 10.0 109.545 172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.1 m -68.33 -31.92 71.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.443 1.897 . . . . 10.0 114.009 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -53.12 -29.88 33.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 10.0 112.73 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.22 89.82 36.43 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 105.686 -1.968 . . . . 10.0 105.686 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -90.67 47.44 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.187 3.925 . . . . 10.0 109.872 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -122.92 -66.01 1.05 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.297 1.839 . . . . 10.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.9 t -59.69 -36.57 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.763 2.025 . . . . 10.0 111.067 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -57.05 -64.48 2.51 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 117.036 -1.459 . . . . 10.0 111.82 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.34 -35.66 49.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.941 2.428 . . . . 10.0 113.354 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 13.5 tm-20 -61.87 -39.77 93.07 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.997 1.272 . . . . 10.0 112.134 -176.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.48 -35.78 27.09 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.228 -0.92 . . . . 10.0 113.123 171.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.66 -31.06 71.86 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.008 -1.057 . . . . 10.0 112.121 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -50.96 -58.25 6.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.027 0.931 . . . . 10.0 111.017 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.475 ' HZ1' ' CD ' ' A' ' 175' ' ' GLU . 48.3 mttp -52.92 -44.08 66.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.053 -1.029 . . . . 10.0 111.13 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.4 mtm -63.72 -46.34 85.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.098 0.959 . . . . 10.0 113.553 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.62 -52.59 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.69 -29.69 70.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.781 -0.628 . . . . 10.0 111.832 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 t -72.06 -47.24 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.743 1.156 . . . . 10.0 111.105 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.24 -36.41 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.172 0.896 . . . . 10.0 110.373 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -43.99 85.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.552 1.141 . . . . 10.0 111.478 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.455 1.502 . . . . 10.0 112.738 173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.28 -51.7 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.757 1.223 . . . . 10.0 111.723 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.541 ' CG ' ' HZ2' ' A' ' 223' ' ' LYS . 12.9 t0 -71.75 -41.6 68.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.044 1.338 . . . . 10.0 110.811 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.482 1.113 . . . . 10.0 113.957 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 192' ' ' THR . 7.1 mt -79.11 -31.84 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.79 1.177 . . . . 10.0 110.633 163.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 m 64.79 -18.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 128.591 2.756 . . . . 10.0 114.629 167.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 190' ' ' ILE . 6.9 m -83.86 -0.53 51.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 129.494 3.117 . . . . 10.0 111.086 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.15 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 128.195 2.598 . . . . 10.0 111.039 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.44 165.31 8.0 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.609 2.873 . . . . 10.0 110.381 168.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.37 137.88 54.93 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.202 1.001 . . . . 10.0 111.208 167.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -119.87 100.77 7.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.087 162.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 m -74.79 122.45 87.51 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 123.495 0.718 . . . . 10.0 109.539 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.92 137.76 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.205 1.937 . . . . 10.0 110.952 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.78 100.85 5.23 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.378 1.085 . . . . 10.0 111.748 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -83.49 115.4 22.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.144 0.978 . . . . 10.0 109.574 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.11 120.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 18.6 t -78.02 139.26 39.11 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.622 -0.674 . . . . 10.0 110.706 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.9 pt -91.27 -3.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 162.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -101.29 114.74 65.71 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.898 0.879 . . . . 10.0 110.966 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -106.38 -6.69 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.852 3.701 . . . . 10.0 113.372 170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -111.07 21.48 16.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.729 1.212 . . . . 10.0 112.19 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -174.25 -48.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.902 2.881 . . . . 10.0 109.313 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.06 91.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.836 1.654 . . . . 10.0 110.545 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 90.4 m -83.17 152.56 25.2 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.842 1.657 . . . . 10.0 108.943 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -54.21 -34.94 61.79 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.13 -0.938 . . . . 10.0 113.086 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.85 -42.21 99.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.325 1.45 . . . . 10.0 113.77 171.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.24 75.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.613 -0.679 . . . . 10.0 110.182 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 97.7 mt -57.27 -45.69 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.029 0.932 . . . . 10.0 110.841 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.71 72.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.634 1.174 . . . . 10.0 112.618 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -61.76 -51.39 68.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.049 -0.501 . . . . 10.0 111.71 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.55 -38.32 74.56 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.547 0.612 . . . . 10.0 112.018 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.89 -50.46 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 10.0 112.114 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -71.09 -17.02 62.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 -175.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.8 -31.4 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.267 0.939 . . . . 10.0 110.959 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.08 -53.44 5.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.486 0.714 . . . . 10.0 111.74 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -171.57 139.17 1.12 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.462 1.105 . . . . 10.0 110.392 166.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.43 -15.17 48.55 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.009 2.473 . . . . 10.0 113.959 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . 0.541 ' HZ2' ' CG ' ' A' ' 188' ' ' ASP . 54.7 tttt -75.91 -16.29 60.05 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.308 0.958 . . . . 10.0 113.551 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.76 152.13 37.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.279 1.032 . . . . 10.0 111.454 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.41 136.3 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.974 0.509 . . . . 10.0 109.867 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.92 132.15 10.22 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 125.3 1.428 . . . . 10.0 112.93 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.51 147.79 45.95 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.819 1.247 . . . . 10.0 112.863 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.0 m -161.98 135.52 6.36 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.807 2.043 . . . . 10.0 110.552 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -111.93 -159.21 14.9 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 109.87 -1.292 . . . . 10.0 109.87 166.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -73.64 162.16 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 122.429 1.109 . . . . 10.0 108.761 156.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -42.83 -38.37 2.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.075 2.55 . . . . 10.0 112.592 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -75.61 -28.78 58.99 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.89 2.076 . . . . 10.0 112.449 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -81.93 -30.94 31.57 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.36 -1.463 . . . . 10.0 111.356 169.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.24 -40.99 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.622 1.169 . . . . 10.0 110.57 166.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.23 -59.59 4.46 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 117.113 -1.422 . . . . 10.0 109.691 161.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -43.38 -49.57 7.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.555 1.98 . . . . 10.0 114.831 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -67.72 -44.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 121.365 1.893 . . . . 10.0 113.239 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.0 -34.47 78.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.153 0.581 . . . . 10.0 111.806 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -78.01 -38.48 44.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.425 2.69 . . . . 10.0 112.473 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.87 -53.19 42.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.499 1.045 . . . . 10.0 112.57 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -76.2 -13.91 60.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 61.4 51.67 4.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.637 1.975 . . . . 10.0 111.659 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.45 155.91 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.092 0.957 . . . . 10.0 110.11 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -97.18 148.3 23.21 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -153.76 134.36 13.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.236 1.414 . . . . 10.0 110.555 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -103.23 104.29 39.88 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 121.318 -0.864 . . . . 10.0 111.859 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.94 136.98 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.794 2.329 . . . . 10.0 111.96 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.71 167.2 19.75 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.173 1.368 . . . . 10.0 112.584 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.18 -170.69 1.02 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.106 3.204 . . . . 10.0 110.998 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 156.58 44.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.802 0.841 . . . . 10.0 112.744 165.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.21 -59.19 1.89 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.272 1.029 . . . . 10.0 110.128 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -98.84 -116.54 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.229 1.412 . . . . 10.0 112.557 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -82.3 52.35 2.01 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.752 1.614 . . . . 10.0 114.248 -162.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 62.72 6.56 2.14 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 117.275 2.324 . . . . 10.0 117.275 166.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.92 65.3 6.01 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.522 -1.361 . . . . 10.0 113.261 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -57.66 135.83 56.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.499 -1.376 . . . . 10.0 111.527 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.3 mt -106.7 146.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.173 1.389 . . . . 10.0 109.523 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.24 131.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.948 1.299 . . . . 10.0 108.77 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.58 120.72 17.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.811 1.245 . . . . 10.0 109.223 168.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . 0.405 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.4 p80 -93.98 86.13 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.017 -0.427 . . . . 10.0 109.9 165.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.0 131.07 39.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.049 0.928 . . . . 10.0 109.499 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.8 mt -90.68 77.66 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.762 -1.108 . . . . 10.0 110.386 -143.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 70.9 mt -122.69 141.97 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.026 1.73 . . . . 10.0 109.946 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttt -141.06 120.2 12.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.717 1.207 . . . . 10.0 110.915 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.71 135.14 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.693 1.197 . . . . 10.0 111.613 -167.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.0 126.48 46.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.343 1.057 . . . . 10.0 110.249 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.87 134.1 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.585 1.554 . . . . 10.0 108.915 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -101.32 178.66 27.97 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.38 0.991 . . . . 10.0 113.157 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 271' ' ' GLY . 56.5 Cg_endo -60.77 158.72 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.323 2.682 . . . . 10.0 110.278 169.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 70.33 -19.82 0.21 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.751 2.42 . . . . 10.0 112.501 -157.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 269' ' ' PRO . . . 97.69 18.49 27.61 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.025 1.774 . . . . 10.0 115.428 167.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.517 ' CD ' ' HZ2' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -97.09 157.02 16.12 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.558 1.179 . . . . 10.0 112.776 -175.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -72.86 144.03 47.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.601 1.96 . . . . 10.0 113.043 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.64 -31.74 1.54 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.251 1.575 . . . . 10.0 115.251 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -158.23 150.96 22.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.19 1.396 . . . . 10.0 109.872 -173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -115.2 120.07 38.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.553 1.168 . . . . 10.0 111.327 162.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -100.03 -163.03 0.99 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.559 2.743 . . . . 10.0 109.615 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.68 -164.16 13.55 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.362 1.934 . . . . 10.0 108.656 -163.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -48.28 147.98 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.971 1.1 . . . . 10.0 113.971 -171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 88.77 -37.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.058 2.543 . . . . 10.0 113.898 165.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -64.93 116.69 6.64 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.803 1.638 . . . . 10.0 109.471 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.38 155.54 38.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.195 -0.94 . . . . 10.0 109.942 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -49.34 -47.5 47.24 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.986 -1.071 . . . . 10.0 113.218 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.91 -22.45 75.72 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.344 -0.698 . . . . 10.0 114.572 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -73.92 -27.74 61.19 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.166 1.483 . . . . 10.0 111.605 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.19 -46.86 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.469 0.708 . . . . 10.0 109.234 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.48 76.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.479 -0.772 . . . . 10.0 112.813 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.49 82.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.577 1.535 . . . . 10.0 113.139 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -61.87 -54.27 44.44 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.488 -0.757 . . . . 10.0 111.262 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.7 mt -60.4 -38.39 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.078 -1.014 . . . . 10.0 111.978 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.7 67.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.687 -1.258 . . . . 10.0 113.11 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.8 m -75.36 -46.34 33.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.602 0.761 . . . . 10.0 110.354 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.77 -24.58 66.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.974 1.31 . . . . 10.0 113.326 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 mmm -63.31 -12.48 30.03 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.71 -1.244 . . . . 10.0 113.676 168.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -71.84 -58.18 3.62 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 116.935 -1.507 . . . . 10.0 112.744 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.05 -59.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.722 2.281 . . . . 10.0 113.272 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -84.4 28.5 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.842 1.657 . . . . 10.0 112.363 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -47.52 137.82 8.51 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 128.795 2.838 . . . . 10.0 113.75 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -56.67 18.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.58 1.152 . . . . 10.0 112.926 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -156.28 -7.1 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.149 1.779 . . . . 10.0 112.227 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 -108.547 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -163.12 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 129.766 3.226 . . . . 10.0 112.723 -6.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 177.99 0.79 Allowed 'General case' 0 N--CA 1.476 0.831 1 C-N-CA 132.076 4.151 . . . . 10.0 111.953 -0.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.47 16.16 24.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.91 1.719 . . . . 10.0 113.529 165.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 8.8 tmtt? -155.45 132.94 6.5 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 118.749 1.275 . . . . 10.0 110.541 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.89 147.35 39.0 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.174 2.583 . . . . 10.0 112.902 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 135' ' ' LEU . 1.4 pt? -79.17 44.44 0.58 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.004 2.122 . . . . 10.0 113.726 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 mp -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.11 1.364 . . . . 10.0 113.448 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.95 -119.05 4.96 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.4 -2.28 . . . . 10.0 107.4 -153.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 160.83 34.44 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 122.429 -0.454 . . . . 10.0 114.163 163.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.64 50.85 2.74 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.34 2.694 . . . . 10.0 109.987 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.33 159.1 21.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.641 0.608 . . . . 10.0 112.641 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.0 p -139.94 63.23 1.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.557 0.947 . . . . 10.0 113.557 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.29 139.12 31.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 119.447 -2.033 . . . . 10.0 112.687 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.5 m -70.71 151.72 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.439 1.496 . . . . 10.0 109.168 170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 p -103.24 154.26 19.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.12 1.368 . . . . 10.0 111.658 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -56.63 -21.91 30.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 10.0 113.361 164.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -78.51 -9.78 59.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.841 2.056 . . . . 10.0 112.322 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 -8.94 73.64 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.636 1.112 . . . . 10.0 114.318 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.38 179.86 7.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.643 1.577 . . . . 10.0 110.188 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.5 103.16 4.06 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.58 -1.325 . . . . 10.0 111.34 -167.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 162.04 13.64 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.659 1.355 . . . . 10.0 114.659 -170.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -117.82 175.84 5.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.537 1.535 . . . . 10.0 109.383 158.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -70.3 -22.11 62.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.099 1.36 . . . . 10.0 113.252 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -12.16 47.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.1 1.148 . . . . 10.0 114.1 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -27.62 69.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.633 1.573 . . . . 10.0 111.501 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -94.93 6.23 49.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.402 1.481 . . . . 10.0 114.346 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.68 106.53 1.2 Allowed 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.277 -0.89 . . . . 10.0 111.307 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 153.18 -37.63 0.74 Allowed Glycine 0 N--CA 1.47 0.941 0 C-N-CA 124.076 0.846 . . . . 10.0 113.412 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -166.06 1.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.582 1.153 . . . . 10.0 110.101 167.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -103.75 169.89 8.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.457 1.103 . . . . 10.0 111.644 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.53 155.2 49.53 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.509 1.124 . . . . 10.0 112.043 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -120.16 120.18 35.45 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.949 -1.5 . . . . 10.0 106.949 154.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mt -105.52 131.81 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.635 1.174 . . . . 10.0 108.885 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -140.21 135.4 32.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.125 0.97 . . . . 10.0 111.722 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.76 114.52 26.17 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.762 0.825 . . . . 10.0 110.77 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.5 167.69 13.28 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.877 1.703 . . . . 10.0 114.319 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 35.6 t80 -159.1 114.7 2.55 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.431 1.092 . . . . 10.0 109.545 172.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.1 m -68.33 -31.92 71.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.443 1.897 . . . . 10.0 114.009 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 168' ' ' HIS . 7.0 m-70 -53.12 -29.88 33.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 10.0 112.73 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.22 89.82 36.43 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 105.686 -1.968 . . . . 10.0 105.686 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -90.67 47.44 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.187 3.925 . . . . 10.0 109.872 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -122.92 -66.01 1.05 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.297 1.839 . . . . 10.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.9 t -59.69 -36.57 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.763 2.025 . . . . 10.0 111.067 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -57.05 -64.48 2.51 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 117.036 -1.459 . . . . 10.0 111.82 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.34 -35.66 49.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.941 2.428 . . . . 10.0 113.354 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -61.87 -39.77 93.07 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.997 1.272 . . . . 10.0 112.134 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.48 -35.78 27.09 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.228 -0.92 . . . . 10.0 113.123 171.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.66 -31.06 71.86 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.008 -1.057 . . . . 10.0 112.121 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -50.96 -58.25 6.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.027 0.931 . . . . 10.0 111.017 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -52.92 -44.08 66.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.053 -1.029 . . . . 10.0 111.13 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.4 mtm -63.72 -46.34 85.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.098 0.959 . . . . 10.0 113.553 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.62 -52.59 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 57.7 mt-30 -62.69 -29.69 70.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.781 -0.628 . . . . 10.0 111.832 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 t -72.06 -47.24 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.743 1.156 . . . . 10.0 111.105 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.24 -36.41 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.172 0.896 . . . . 10.0 110.373 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -43.99 85.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.552 1.141 . . . . 10.0 111.478 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.455 1.502 . . . . 10.0 112.738 173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.28 -51.7 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.757 1.223 . . . . 10.0 111.723 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -71.75 -41.6 68.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.044 1.338 . . . . 10.0 110.811 -171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.482 1.113 . . . . 10.0 113.957 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 192' ' ' THR . 7.1 mt -79.11 -31.84 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.79 1.177 . . . . 10.0 110.633 163.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 m 64.79 -18.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 128.591 2.756 . . . . 10.0 114.629 167.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 190' ' ' ILE . 6.9 m -83.86 -0.53 51.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 129.494 3.117 . . . . 10.0 111.086 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.15 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 128.195 2.598 . . . . 10.0 111.039 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.44 165.31 8.0 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.609 2.873 . . . . 10.0 110.381 168.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.37 137.88 54.93 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.202 1.001 . . . . 10.0 111.208 167.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -119.87 100.77 7.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.087 162.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 m -74.79 122.45 87.51 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 123.495 0.718 . . . . 10.0 109.539 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.92 137.76 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.205 1.937 . . . . 10.0 110.952 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.78 100.85 5.23 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.378 1.085 . . . . 10.0 111.748 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -83.49 115.4 22.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.144 0.978 . . . . 10.0 109.574 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.11 120.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 18.6 t -78.02 139.26 39.11 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.622 -0.674 . . . . 10.0 110.706 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.9 pt -91.27 -3.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 162.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -101.29 114.74 65.71 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.898 0.879 . . . . 10.0 110.966 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -106.38 -6.69 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.852 3.701 . . . . 10.0 113.372 170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -111.07 21.48 16.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.729 1.212 . . . . 10.0 112.19 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -174.25 -48.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.902 2.881 . . . . 10.0 109.313 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.06 91.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.836 1.654 . . . . 10.0 110.545 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 90.4 m -83.17 152.56 25.2 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.842 1.657 . . . . 10.0 108.943 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -54.21 -34.94 61.79 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.13 -0.938 . . . . 10.0 113.086 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.85 -42.21 99.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.325 1.45 . . . . 10.0 113.77 171.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.24 75.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.613 -0.679 . . . . 10.0 110.182 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 97.7 mt -57.27 -45.69 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.029 0.932 . . . . 10.0 110.841 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.71 72.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.634 1.174 . . . . 10.0 112.618 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -61.76 -51.39 68.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.049 -0.501 . . . . 10.0 111.71 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.55 -38.32 74.56 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.547 0.612 . . . . 10.0 112.018 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.89 -50.46 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 10.0 112.114 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -71.09 -17.02 62.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 -175.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.8 -31.4 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.267 0.939 . . . . 10.0 110.959 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.08 -53.44 5.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.486 0.714 . . . . 10.0 111.74 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -171.57 139.17 1.12 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.462 1.105 . . . . 10.0 110.392 166.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.43 -15.17 48.55 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.009 2.473 . . . . 10.0 113.959 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -75.91 -16.29 60.05 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.308 0.958 . . . . 10.0 113.551 171.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.76 152.13 37.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.279 1.032 . . . . 10.0 111.454 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.41 136.3 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.974 0.509 . . . . 10.0 109.867 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.92 132.15 10.22 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 125.3 1.428 . . . . 10.0 112.93 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.51 147.79 45.95 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.819 1.247 . . . . 10.0 112.863 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.0 m -161.98 135.52 6.36 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.807 2.043 . . . . 10.0 110.552 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -111.93 -159.21 14.9 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 109.87 -1.292 . . . . 10.0 109.87 166.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -73.64 162.16 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 122.429 1.109 . . . . 10.0 108.761 156.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -42.83 -38.37 2.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.075 2.55 . . . . 10.0 112.592 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -75.61 -28.78 58.99 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.89 2.076 . . . . 10.0 112.449 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -81.93 -30.94 31.57 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.36 -1.463 . . . . 10.0 111.356 169.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.24 -40.99 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.622 1.169 . . . . 10.0 110.57 166.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.23 -59.59 4.46 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 117.113 -1.422 . . . . 10.0 109.691 161.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -43.38 -49.57 7.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.555 1.98 . . . . 10.0 114.831 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -67.72 -44.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 121.365 1.893 . . . . 10.0 113.239 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.0 -34.47 78.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.153 0.581 . . . . 10.0 111.806 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -78.01 -38.48 44.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.425 2.69 . . . . 10.0 112.473 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.87 -53.19 42.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.499 1.045 . . . . 10.0 112.57 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -76.2 -13.91 60.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 61.4 51.67 4.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.637 1.975 . . . . 10.0 111.659 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.45 155.91 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.092 0.957 . . . . 10.0 110.11 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -97.18 148.3 23.21 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -153.76 134.36 13.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.236 1.414 . . . . 10.0 110.555 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -103.23 104.29 39.88 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 121.318 -0.864 . . . . 10.0 111.859 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.94 136.98 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.794 2.329 . . . . 10.0 111.96 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.71 167.2 19.75 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.173 1.368 . . . . 10.0 112.584 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.18 -170.69 1.02 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.106 3.204 . . . . 10.0 110.998 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 156.58 44.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.802 0.841 . . . . 10.0 112.744 165.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.21 -59.19 1.89 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.272 1.029 . . . . 10.0 110.128 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -98.84 -116.54 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.229 1.412 . . . . 10.0 112.557 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -82.3 52.35 2.01 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.752 1.614 . . . . 10.0 114.248 -162.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 62.72 6.56 2.14 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 117.275 2.324 . . . . 10.0 117.275 166.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.92 65.3 6.01 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.522 -1.361 . . . . 10.0 113.261 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -57.66 135.83 56.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.499 -1.376 . . . . 10.0 111.527 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.3 mt -106.7 146.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.173 1.389 . . . . 10.0 109.523 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.24 131.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.948 1.299 . . . . 10.0 108.77 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.58 120.72 17.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.811 1.245 . . . . 10.0 109.223 168.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . 0.405 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.4 p80 -93.98 86.13 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.017 -0.427 . . . . 10.0 109.9 165.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.0 131.07 39.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.049 0.928 . . . . 10.0 109.499 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.8 mt -90.68 77.66 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.762 -1.108 . . . . 10.0 110.386 -143.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 70.9 mt -122.69 141.97 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.026 1.73 . . . . 10.0 109.946 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttt -141.06 120.2 12.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.717 1.207 . . . . 10.0 110.915 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.71 135.14 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.693 1.197 . . . . 10.0 111.613 -167.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.0 126.48 46.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.343 1.057 . . . . 10.0 110.249 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.87 134.1 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.585 1.554 . . . . 10.0 108.915 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -101.32 178.66 27.97 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.38 0.991 . . . . 10.0 113.157 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -60.77 158.72 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.323 2.682 . . . . 10.0 110.278 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 70.33 -19.82 0.21 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.751 2.42 . . . . 10.0 112.501 -157.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.69 18.49 27.61 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.025 1.774 . . . . 10.0 115.428 167.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.467 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -97.09 157.02 16.12 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.558 1.179 . . . . 10.0 112.776 -175.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -72.86 144.03 47.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.601 1.96 . . . . 10.0 113.043 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.64 -31.74 1.54 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.251 1.575 . . . . 10.0 115.251 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -158.23 150.96 22.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.19 1.396 . . . . 10.0 109.872 -173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -115.2 120.07 38.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.553 1.168 . . . . 10.0 111.327 162.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -100.03 -163.03 0.99 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.559 2.743 . . . . 10.0 109.615 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.68 -164.16 13.55 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.362 1.934 . . . . 10.0 108.656 -163.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -48.28 147.98 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.971 1.1 . . . . 10.0 113.971 -171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 88.77 -37.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.058 2.543 . . . . 10.0 113.898 165.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -64.93 116.69 6.64 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.803 1.638 . . . . 10.0 109.471 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.38 155.54 38.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.195 -0.94 . . . . 10.0 109.942 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.8 tmtt? -49.34 -47.5 47.24 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.986 -1.071 . . . . 10.0 113.218 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.91 -22.45 75.72 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.344 -0.698 . . . . 10.0 114.572 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -73.92 -27.74 61.19 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.166 1.483 . . . . 10.0 111.605 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.19 -46.86 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.469 0.708 . . . . 10.0 109.234 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.48 76.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.479 -0.772 . . . . 10.0 112.813 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.49 82.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.577 1.535 . . . . 10.0 113.139 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -61.87 -54.27 44.44 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.488 -0.757 . . . . 10.0 111.262 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.7 mt -60.4 -38.39 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.078 -1.014 . . . . 10.0 111.978 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.7 67.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.687 -1.258 . . . . 10.0 113.11 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.8 m -75.36 -46.34 33.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.602 0.761 . . . . 10.0 110.354 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.77 -24.58 66.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.974 1.31 . . . . 10.0 113.326 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 mmm -63.31 -12.48 30.03 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.71 -1.244 . . . . 10.0 113.676 168.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -71.84 -58.18 3.62 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 116.935 -1.507 . . . . 10.0 112.744 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.05 -59.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.722 2.281 . . . . 10.0 113.272 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -84.4 28.5 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.842 1.657 . . . . 10.0 112.363 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -47.52 137.82 8.51 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 128.795 2.838 . . . . 10.0 113.75 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -56.67 18.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.58 1.152 . . . . 10.0 112.926 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -156.28 -7.1 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.149 1.779 . . . . 10.0 112.227 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 -108.547 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -163.12 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 129.766 3.226 . . . . 10.0 112.723 -6.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 177.99 0.79 Allowed 'General case' 0 N--CA 1.476 0.831 1 C-N-CA 132.076 4.151 . . . . 10.0 111.953 -0.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.47 16.16 24.38 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.91 1.719 . . . . 10.0 113.529 165.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.467 ' HZ1' ' CD ' ' A' ' 272' ' ' GLU . 8.8 tmtt? -155.45 132.94 6.5 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 118.749 1.275 . . . . 10.0 110.541 -175.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.89 147.35 39.0 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.174 2.583 . . . . 10.0 112.902 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 135' ' ' LEU . 1.4 pt? -79.17 44.44 0.58 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.004 2.122 . . . . 10.0 113.726 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 mp -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.11 1.364 . . . . 10.0 113.448 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.95 -119.05 4.96 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.4 -2.28 . . . . 10.0 107.4 -153.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 160.83 34.44 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 122.429 -0.454 . . . . 10.0 114.163 163.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.64 50.85 2.74 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.34 2.694 . . . . 10.0 109.987 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.33 159.1 21.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.641 0.608 . . . . 10.0 112.641 -175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.0 p -139.94 63.23 1.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.557 0.947 . . . . 10.0 113.557 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.9 mt -91.29 139.12 31.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 119.447 -2.033 . . . . 10.0 112.687 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.5 m -70.71 151.72 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.439 1.496 . . . . 10.0 109.168 170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 p -103.24 154.26 19.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.12 1.368 . . . . 10.0 111.658 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -56.63 -21.91 30.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.008 1.723 . . . . 10.0 113.361 164.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -78.51 -9.78 59.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.841 2.056 . . . . 10.0 112.322 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.78 -8.94 73.64 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.636 1.112 . . . . 10.0 114.318 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.38 179.86 7.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.643 1.577 . . . . 10.0 110.188 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.5 103.16 4.06 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.58 -1.325 . . . . 10.0 111.34 -167.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 162.04 13.64 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.659 1.355 . . . . 10.0 114.659 -170.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -117.82 175.84 5.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.537 1.535 . . . . 10.0 109.383 158.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -70.3 -22.11 62.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.099 1.36 . . . . 10.0 113.252 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -12.16 47.58 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.1 1.148 . . . . 10.0 114.1 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -27.62 69.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.633 1.573 . . . . 10.0 111.501 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -94.93 6.23 49.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.402 1.481 . . . . 10.0 114.346 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.68 106.53 1.2 Allowed 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.277 -0.89 . . . . 10.0 111.307 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 153.18 -37.63 0.74 Allowed Glycine 0 N--CA 1.47 0.941 0 C-N-CA 124.076 0.846 . . . . 10.0 113.412 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -166.06 1.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.582 1.153 . . . . 10.0 110.101 167.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -103.75 169.89 8.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.457 1.103 . . . . 10.0 111.644 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.0 mt -137.53 155.2 49.53 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.509 1.124 . . . . 10.0 112.043 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 13.7 mt -120.16 120.18 35.45 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.949 -1.5 . . . . 10.0 106.949 154.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mt -105.52 131.81 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.635 1.174 . . . . 10.0 108.885 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -140.21 135.4 32.34 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.125 0.97 . . . . 10.0 111.722 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.76 114.52 26.17 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.762 0.825 . . . . 10.0 110.77 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -108.5 167.69 13.28 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.877 1.703 . . . . 10.0 114.319 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' A' ' 260' ' ' HIS . 35.6 t80 -159.1 114.7 2.55 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.431 1.092 . . . . 10.0 109.545 172.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.1 m -68.33 -31.92 71.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.443 1.897 . . . . 10.0 114.009 -165.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 168' ' ' HIS . 7.0 m-70 -53.12 -29.88 33.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.633 1.573 . . . . 10.0 112.73 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.22 89.82 36.43 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 105.686 -1.968 . . . . 10.0 105.686 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -90.67 47.44 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 125.187 3.925 . . . . 10.0 109.872 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -122.92 -66.01 1.05 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.297 1.839 . . . . 10.0 110.265 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.9 t -59.69 -36.57 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.763 2.025 . . . . 10.0 111.067 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 260' ' ' HIS . 92.7 m -57.05 -64.48 2.51 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 117.036 -1.459 . . . . 10.0 111.82 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.34 -35.66 49.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.941 2.428 . . . . 10.0 113.354 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -61.87 -39.77 93.07 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.997 1.272 . . . . 10.0 112.134 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.48 -35.78 27.09 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.228 -0.92 . . . . 10.0 113.123 171.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.66 -31.06 71.86 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.008 -1.057 . . . . 10.0 112.121 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -50.96 -58.25 6.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.027 0.931 . . . . 10.0 111.017 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -52.92 -44.08 66.74 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.053 -1.029 . . . . 10.0 111.13 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.4 mtm -63.72 -46.34 85.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.098 0.959 . . . . 10.0 113.553 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.62 -52.59 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 57.7 mt-30 -62.69 -29.69 70.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 118.781 -0.628 . . . . 10.0 111.832 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 t -72.06 -47.24 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 119.743 1.156 . . . . 10.0 111.105 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.24 -36.41 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.172 0.896 . . . . 10.0 110.373 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -43.99 85.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.552 1.141 . . . . 10.0 111.478 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -63.81 -31.7 72.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.455 1.502 . . . . 10.0 112.738 173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.28 -51.7 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.757 1.223 . . . . 10.0 111.723 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -71.75 -41.6 68.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.044 1.338 . . . . 10.0 110.811 -171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.482 1.113 . . . . 10.0 113.957 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 192' ' ' THR . 7.1 mt -79.11 -31.84 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.79 1.177 . . . . 10.0 110.633 163.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 m 64.79 -18.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 128.591 2.756 . . . . 10.0 114.629 167.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 190' ' ' ILE . 6.9 m -83.86 -0.53 51.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 129.494 3.117 . . . . 10.0 111.086 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.15 -177.9 0.54 Allowed Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 128.195 2.598 . . . . 10.0 111.039 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.44 165.31 8.0 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.609 2.873 . . . . 10.0 110.381 168.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.37 137.88 54.93 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.202 1.001 . . . . 10.0 111.208 167.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 tt -119.87 100.77 7.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.087 162.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 m -74.79 122.45 87.51 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 123.495 0.718 . . . . 10.0 109.539 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.92 137.76 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.205 1.937 . . . . 10.0 110.952 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.78 100.85 5.23 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.378 1.085 . . . . 10.0 111.748 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -83.49 115.4 22.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.144 0.978 . . . . 10.0 109.574 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 42.8 mt -99.11 120.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 18.6 t -78.02 139.26 39.11 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.622 -0.674 . . . . 10.0 110.706 168.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 9.9 pt -91.27 -3.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 162.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -101.29 114.74 65.71 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.898 0.879 . . . . 10.0 110.966 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -106.38 -6.69 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.852 3.701 . . . . 10.0 113.372 170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -111.07 21.48 16.35 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.729 1.212 . . . . 10.0 112.19 -155.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -174.25 -48.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.902 2.881 . . . . 10.0 109.313 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.06 91.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.836 1.654 . . . . 10.0 110.545 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 90.4 m -83.17 152.56 25.2 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.842 1.657 . . . . 10.0 108.943 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -54.21 -34.94 61.79 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.13 -0.938 . . . . 10.0 113.086 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.85 -42.21 99.65 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.325 1.45 . . . . 10.0 113.77 171.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.24 75.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.613 -0.679 . . . . 10.0 110.182 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 97.7 mt -57.27 -45.69 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.029 0.932 . . . . 10.0 110.841 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.71 72.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.634 1.174 . . . . 10.0 112.618 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -61.76 -51.39 68.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.049 -0.501 . . . . 10.0 111.71 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.55 -38.32 74.56 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.547 0.612 . . . . 10.0 112.018 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.89 -50.46 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 10.0 112.114 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.266 0.1 OUTLIER -71.09 -17.02 62.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 -175.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.8 -31.4 72.0 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.267 0.939 . . . . 10.0 110.959 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.08 -53.44 5.8 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.486 0.714 . . . . 10.0 111.74 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -171.57 139.17 1.12 Allowed Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.462 1.105 . . . . 10.0 110.392 166.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.43 -15.17 48.55 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.009 2.473 . . . . 10.0 113.959 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -75.91 -16.29 60.05 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.308 0.958 . . . . 10.0 113.551 171.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.76 152.13 37.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.279 1.032 . . . . 10.0 111.454 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.41 136.3 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.974 0.509 . . . . 10.0 109.867 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -114.92 132.15 10.22 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 125.3 1.428 . . . . 10.0 112.93 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.51 147.79 45.95 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.819 1.247 . . . . 10.0 112.863 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 2.0 m -161.98 135.52 6.36 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.807 2.043 . . . . 10.0 110.552 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -111.93 -159.21 14.9 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 109.87 -1.292 . . . . 10.0 109.87 166.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -73.64 162.16 29.51 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 122.429 1.109 . . . . 10.0 108.761 156.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -42.83 -38.37 2.13 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.075 2.55 . . . . 10.0 112.592 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -75.61 -28.78 58.99 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.89 2.076 . . . . 10.0 112.449 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -81.93 -30.94 31.57 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.36 -1.463 . . . . 10.0 111.356 169.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.24 -40.99 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.622 1.169 . . . . 10.0 110.57 166.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.23 -59.59 4.46 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 117.113 -1.422 . . . . 10.0 109.691 161.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -43.38 -49.57 7.0 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.555 1.98 . . . . 10.0 114.831 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -67.72 -44.62 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 121.365 1.893 . . . . 10.0 113.239 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.0 -34.47 78.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.153 0.581 . . . . 10.0 111.806 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -78.01 -38.48 44.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.425 2.69 . . . . 10.0 112.473 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.87 -53.19 42.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.499 1.045 . . . . 10.0 112.57 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -76.2 -13.91 60.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 61.4 51.67 4.08 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.637 1.975 . . . . 10.0 111.659 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.45 155.91 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.092 0.957 . . . . 10.0 110.11 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -97.18 148.3 23.21 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -153.76 134.36 13.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.236 1.414 . . . . 10.0 110.555 167.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -103.23 104.29 39.88 Favored Pre-proline 0 N--CA 1.471 0.607 0 O-C-N 121.318 -0.864 . . . . 10.0 111.859 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.94 136.98 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.794 2.329 . . . . 10.0 111.96 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -100.71 167.2 19.75 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.173 1.368 . . . . 10.0 112.584 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -78.18 -170.69 1.02 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.106 3.204 . . . . 10.0 110.998 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 156.58 44.31 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.802 0.841 . . . . 10.0 112.744 165.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.21 -59.19 1.89 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.272 1.029 . . . . 10.0 110.128 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -98.84 -116.54 0.15 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.229 1.412 . . . . 10.0 112.557 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -82.3 52.35 2.01 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.752 1.614 . . . . 10.0 114.248 -162.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 62.72 6.56 2.14 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 117.275 2.324 . . . . 10.0 117.275 166.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.92 65.3 6.01 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.522 -1.361 . . . . 10.0 113.261 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -57.66 135.83 56.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.499 -1.376 . . . . 10.0 111.527 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 44.3 mt -106.7 146.05 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.173 1.389 . . . . 10.0 109.523 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.8 t -139.24 131.63 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.948 1.299 . . . . 10.0 108.77 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.58 120.72 17.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.811 1.245 . . . . 10.0 109.223 168.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . 0.405 ' CE1' ' SG ' ' A' ' 173' ' ' CYS . 5.4 p80 -93.98 86.13 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.017 -0.427 . . . . 10.0 109.9 165.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.0 131.07 39.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.049 0.928 . . . . 10.0 109.499 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.8 mt -90.68 77.66 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.762 -1.108 . . . . 10.0 110.386 -143.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 70.9 mt -122.69 141.97 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.026 1.73 . . . . 10.0 109.946 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 7.9 ttt -141.06 120.2 12.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.717 1.207 . . . . 10.0 110.915 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.71 135.14 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.693 1.197 . . . . 10.0 111.613 -167.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.0 126.48 46.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.343 1.057 . . . . 10.0 110.249 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.87 134.1 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.585 1.554 . . . . 10.0 108.915 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -101.32 178.66 27.97 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.38 0.991 . . . . 10.0 113.157 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -60.77 158.72 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.323 2.682 . . . . 10.0 110.278 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 70.33 -19.82 0.21 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.751 2.42 . . . . 10.0 112.501 -157.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.69 18.49 27.61 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 126.025 1.774 . . . . 10.0 115.428 167.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.467 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -97.09 157.02 16.12 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.558 1.179 . . . . 10.0 112.776 -175.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -72.86 144.03 47.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.601 1.96 . . . . 10.0 113.043 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 93.3 mt -131.64 -31.74 1.54 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.251 1.575 . . . . 10.0 115.251 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -158.23 150.96 22.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.19 1.396 . . . . 10.0 109.872 -173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -115.2 120.07 38.5 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.553 1.168 . . . . 10.0 111.327 162.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -100.03 -163.03 0.99 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.559 2.743 . . . . 10.0 109.615 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 119.68 -164.16 13.55 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.362 1.934 . . . . 10.0 108.656 -163.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -48.28 147.98 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.971 1.1 . . . . 10.0 113.971 -171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 88.77 -37.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.058 2.543 . . . . 10.0 113.898 165.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -64.93 116.69 6.64 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.803 1.638 . . . . 10.0 109.471 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.38 155.54 38.7 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.195 -0.94 . . . . 10.0 109.942 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.8 tmtt? -49.34 -47.5 47.24 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.986 -1.071 . . . . 10.0 113.218 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -68.91 -22.45 75.72 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.344 -0.698 . . . . 10.0 114.572 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -73.92 -27.74 61.19 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.166 1.483 . . . . 10.0 111.605 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.19 -46.86 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.469 0.708 . . . . 10.0 109.234 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.48 76.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 118.479 -0.772 . . . . 10.0 112.813 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.49 82.02 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.577 1.535 . . . . 10.0 113.139 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.1 m -61.87 -54.27 44.44 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.488 -0.757 . . . . 10.0 111.262 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 78.7 mt -60.4 -38.39 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.078 -1.014 . . . . 10.0 111.978 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -66.15 -26.7 67.55 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.687 -1.258 . . . . 10.0 113.11 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 96.8 m -75.36 -46.34 33.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.602 0.761 . . . . 10.0 110.354 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.77 -24.58 66.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.974 1.31 . . . . 10.0 113.326 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.1 mmm -63.31 -12.48 30.03 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.71 -1.244 . . . . 10.0 113.676 168.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 71.1 mtt85 -71.84 -58.18 3.62 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 116.935 -1.507 . . . . 10.0 112.744 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.05 -59.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.722 2.281 . . . . 10.0 113.272 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -84.4 28.5 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.842 1.657 . . . . 10.0 112.363 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -47.52 137.82 8.51 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 128.795 2.838 . . . . 10.0 113.75 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -56.67 18.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.58 1.152 . . . . 10.0 112.926 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -156.28 -7.1 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.149 1.779 . . . . 10.0 112.227 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 -108.547 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' NI' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_